We previously demonstrated using noninvasive technologies that the interferon-gamma (IFN-γ) receptor complex is preassembled [1] . In this report we determined how the receptor complex is preassembled and how the ligand-mediated conformational changes occur. The interaction of Stat1 with IFN-γR1 results in a conformational change localized to IFN-γR1. Jak1 but not Jak2 is required for the two chains of the IFN-γ receptor complex (IFN-γR1 and IFN-γR2) to interact; however, the presence of both Jak1 and Jak2 is required to see any ligand-dependant conformational change. Two IFN-γR2 chains interact through species-specific determinants in their extracellular domains. Finally, these determinants also participate in the interaction of IFN-γR2 with IFN-γR1. These results agree with a detailed model of the IFN-γ receptor that requires the receptor chains to be pre-associated constitutively for the receptor to be active.
Introduction
The interferon-gamma (IFN-γ) receptor complex is composed of four transmembrane polypeptides: two ligand-binding chains (IFN-γR1, also known as the α chain), and two accessory chains (IFN-γR2, also known as the β chain) that do not bind IFN-γ independently but are required for IFN-γ to exhibit any biological activity [2] [3] [4] [5] [6] [7] [8] . The structure of the resting IFN-γ receptor complex has been in debate because of conflicting reports based on experiments that destroy the integrity of the cell and hence the receptor's microenvironment [9] [10] [11] [12] . By using confocal microscopy coupled to fluorescence resonance energy transfer (FRET), we demonstrated that the receptor complex in its resting state in intact cells is a preformed tetramer that undergoes a conformational change when cells are treated with IFN-γ [1] . After treatment with IFN-γ, the intracellular domains of the IFN-γR1 and IFN-γR2 chains move apart from one another.
Ligand-dependant conformational changes could come from proteins that are recruited to the activated receptor complex, such as Stat1. The interaction of Stat1 with IFN-γR1 requires the phosphorylation of Tyr-457, which occurs only after the IFN-γ receptor is activated by IFN-γ [13] . This tyrosine residue is part of a motif (Tyr 457 Asp 458 Lys 459 Pro 460 His 461 ) that is highly conserved among tetrapods and is critical for Stat1 recruitment to the active IFN-γ receptor
Material and methods

Cells, media, and reagents
COS-1 and U3A cells (mutant human 2fTGH cells lacking Stat1 [39] ) were maintained in DMEM (Sigma Aldrich) supplemented with 10% (v:v) fetal bovine serum (FBS) . No antibiotics were used during the passaging of these cell lines. Dimethylsulfoxide, chloroquine diphosphate, and diethylaminoethyl-dextran were purchased from Sigma-Aldrich. Lipofectamine was obtained from Qiagen, Inc. (Valencia, CA). Restriction endonucleases and T4 DNA ligase were obtained from New England Biolabs. Shrimp alkaline phosphatase was obtained from Boehringer-Mannheim. IFN-γ was obtained from PBL Biomedical Laboratories (Piscataway, NJ). Thermus acquaticus DNA polymerase was purified according to a published protocol [40] . Cells were treated with 1500 units/mL IFN-γ unless otherwise indicated. Site-directed mutagenesis was performed with the QuikChange Site-directed Mutagenesis Kit from Strategene, Inc. (La Jolla, CA) according to the manufacturer's recommendations. In this report, mutated amino acids are numbered assuming the initial methionine at the beginning of the signal peptide is the first amino acid. Overlapping primers designed to create the Y457F mutant of IFN-γR1/EBFP or IFN-γR1 are (sense) 5'-CCA CCT CCT TTG GTT TTG ATA AAC CAC ATG TG-3' and (antisense) 5'-CAC ATG TGG TTT ATC AAA ACC AAA GGA GGT GG-3'. Overlapping primers designed to create the P284L mutant on IFN-γR1/EGFP or IFN-γR1 are (sense) 5'-GGA AAA AAG CAT AAT AAT ACTTAAGTC CTT GAT CTC TGT GGT AAG-3' and (antisense) 5'-CTT ACC ACA GAG ATC AAG GACTTAAGT AAT ATT ATG CTT TTT TCC-3'. The AflII site in both primers is underlined. Overlapping primers designed to create the PPSIP284-288AAAAA mutant on FL-IFN-γR2/GFP are (sense) 5'-AAA TAC TGG TTT CAC ACT GCC GCGGCCGCT GCC TTA CAG ATA GAA GAG TAT-3' and (antisense) 5'-ATA CTC TTC TAT CTG TAA GGC AGCGGCCGC GGC AGT GTG AAA CCA GTA TTT-3'. The NotI site in both primers is underlined. Nucleotides mutated from their wildtype sequences are in boldface in the sense strand, and anticodons mutated from their wildtype sequences are in boldface in the antisense strand.
Receptor constructs
Hu-IFN-γR2 was expressed with a FLAG epitope (ADY-KDDDDK) on its NH 2 -terminus [41] .
Hu-IFN-γR1 was modified by PCR in two steps in order to place the GFP variants onto the COOH-terminus. The following forward and reverse primers were used to amplify the transmembrane and intracellular domains of IFN-γR1: 5'-GTC GCTAGC GAT TCC AGT TGT TGC TGC T-3' and 5'-GCC GCGGCCGCT AATCCGAG AAA ATT CTT TGG AAT C-3'. The forward primer encodes an NheI restriction endonuclease site (underlined). The nucleotides in boldface encode amino acids that are mutated from the corresponding wild-type sequences. This mutation, encoding the first NH 2 -terminal three amino acids of the transmembrane domain of Hu-IFN-γR1, does not alter its biological function in any tested assay [1, 42] . Each reverse primer encodes a BspEI restriction endonuclease site (single underline), followed by a TAG stop codon, in turn followed by an EagI restriction endonuclease site (double underline). This places a nonanucleotide sequence (in boldface) encoding Asp-Pro and a stop codon in place of the original stop codon of the wildtype receptor sequence. This mutation also does not appear to inhibit the biological function of the receptor (C Krause and S Pestka, unpublished observations). After amplification of the transmembrane and intracellular domains by PCR, the products were digested with NheI and EagI restriction endonucleases and ligated to pEF3-IFN-γR1 [1] digested with NheI and NotI to free their transmembrane and intracellular domains. Ligation of cohesive ends yielded plasmid pEF3-IFN-γR1.
To insert the GFP variants into pEF3-IFN-γR1 and pcDNA3-FL-IFN-γR2, the GFP variants were amplified and the ends of their cDNA are altered by PCR. The following forward primer was used to amplify GFP from pEF2-S65T (derived from plasmid pS65T, a gift from Roger Y Tsien): 5'-GCG CTCCGGATCCCA TGA GTA AAG GAG AAG AAC-3'. The following forward primer was used to amplify EBFP, EGFP, ECFP and EYFP from pEF2-EBFP and pIRES- To create the chimeric receptor MH-IFN-γR2/GFP (where MH denotes a murine/human chimera) in which the extracellular domain is from Mu-IFN-γR2 (Mu, mouse) whereas the transmembrane and intracellular domain is from FL-Hu-IFN-γR2/GFP (Hu, human), we amplified the extracellular domain of Mu-IFN-γR2 from plasmid pcDNA3-Mu-IFN-γR2 [37] by PCR with the following forward and reverse primers: 5'-GAT CGGTACCGG GCC ATG CGG CCT TTG-3' and 5'-CAT GGCTAGCCA TTG CTG CAG CCT GGC GGA G-3', where the KpnI and NheI restriction endonuclease sites used for the subsequent cloning step are underlined. Plasmid pcDNA3-FL-IFN-γR2/GFP was digested with KpnI and NheI, releasing the human extracellular domain. The large fragment retaining the transmembrane and intracellular domains of FL-IFN-γR2/GFP was ligated to the resulting PCR product digested with KpnI and NheI. Ligation of cohesive ends yielded pcDNA3-MH-IFN-γR2/GFP that expressed the chimeric fluorescent receptor MH-IFN-γR2/GFP.
Tandem vectors were synthesized as previously described so that two or more proteins would be co-expressed in a single cell more efficiently than could be achieved by transfection of individual plasmids [1, 41] .
Transfections
Stable transfections were performed in U3A cells with Lipofectamine as previously published [11] . Transient transfections of COS-1 cells with diethylaminoethyl-dextran were performed as reported [1, 41] .
Confocal fluorescence spectroscopy
A custom-built instrument coupling a monochromator to a confocal microscope was described previously [43] with minor enhancements [1] to analyze interactions between GFP-tagged, EGFP-tagged and EBFP-tagged receptor chains. A femtosecond pulsed titanium:sapphire mode-locked tunable infrared laser with argon continuous-wave ion pump laser (both from Coherent, Inc.) was used as the primary excitation source. An independent 15 mW continuous-wave argon-ion laser was used as a secondary excitation source, and 488 nm light was isolated from the multiline argon laser emission with a prism followed by a 488 nm band-pass filter. Infrared light was filtered with a 670DCSP dichroic mirror and a 600SP short pass filter, while 488 nm light was filtered with a 500DCLP dichroic mirror and 488 nm notch filters.
Cells were washed twice with PBS, placed in a 250 mL quartzbottomed (0.17 mm thickness) cylindrical sample well, covered with 200 mL PBS, and were allowed to settle. After settling of cells, cells possessing GFP emission when excited by 488 nm epifluorescent light (derived by defocusing the incident 488 nm laser light) were selected at random for spectral analysis. In some experiments, 380 nm light was used to qualitatively assay FRET in cells known to express GFP as determined above. The 380 nm epifluorescence light was generated from 760 nm light by passing the infrared laser light through a doubling crystal, filtering the remaining infrared light with a 400 nm short-pass filter, and defocusing the 380 nm light prior to exciting the sample. Individual cells were excited by two-photon excitation at 760 nm. Fluorescent light emitted from the samples was directed to either an Acton-150 monochromator (Roper Scientific) to be detected by a LN-CCD512TK back-illumination CCD camera (Roper Scientific) for spectral analysis or to an SPCM avalanche photodiode (Perkin-Elmer) capable of single fluorophore detection for imaging analysis. Spectral data were recorded with an exposure time of five seconds with WinSpec software (Roper Scientific), and were translated into a platform-independent data table format with Igor software (Wavemetrics). A Diaphot 300 (Nikon, Inc.) microscope shell was coupled to a Queensgate confocal scanner/stage micrometer. Areas of the imaging field ranging from 250 × 250 nm 2 (the physical limit set by the frequency of laser light during twophoton excitation and the numerical aperture of the objective lens, which is 1.3 here) to 50 × 50 mm 2 to probe were selected from a single cell for spectral analysis. Unless otherwise noted, areas of at least 0.4 mm 2 were evaluated. At least seven cells expressing GFP were randomly selected for quantitative analysis in each transfection and the results from a representative cell presented. At least thirty more cells expressing GFP were illuminated by 380 nm epifluorescent light to judge FRET visually in cells throughout the population to ensure that a representative sample of the population was analyzed quantitatively.
To analyze FRET between ECFP and EYFP in intact cells, a similar instrument to the one above was designed. An Olympus FV300 confocal system on an IX71 microscope with an automatic stage controller was configured with helium-cadmium solid-state laser (442 nm), multiline argon ion laser (458/488/514 nm), HeNe Green laser (543 nm) and HeNe Red laser (633 nm) lines). Samples were illuminated by either transmitted light and visualized by light microscopy or differential image contrast microscopy (Nomarsky microscopy), by widefield epifluorescence with a mercury lamp as the excitation source, or by laser excitation from either one of the above. The confocal microscope was specially modified with an optional fiber output to couple to other detection devices. Fluorescent light emitted from the sample was directed to either a photomultiplier tube for confocal image analysis or to an Acton SP-150 Spectrophotometer for frequency-resolved photon collection with a CCD camera (Andor Technology, Model DV420) through the fiber output. Inc. (confocal image) or with Andor MCD software from Andor Technology (emission spectra). Emission spectra were calibrated manually with the software package by observing the simultaneous emission of the 488, 514, 543 and 633 nm lasers above.
Results
Stat1 recruitment is required for ligand-dependant alteration in the structure of IFN-γR1
We previously demonstrated that the intracellular domains of the IFN-γR1 and IFN-γR2 move apart or rotate with respect to each other after IFN-γ is added to cells [1] . Stat1 is recruited to the IFN-γ receptor complex after the IFN-γ receptor complex is activated and Tyr-457 of IFN-γR1 is phosphorylated [13] . To test our hypothesis that Stat1 recruitment to Tyr-457 is required for separation of the intracellular domains of the IFN-γ receptor complex, we mutated Tyr-457 of IFN-γR1/EBFP to Phe to prevent Stat1 recruitment. We coexpressed this receptor mutant [Y457F]IFN-γR1/EBFP with FL-IFN-γR2/GFP in COS-1 cells, then measured FRET before and after IFN-γ treatment. Prior to IFN-γ treatment, there was substantial FRET between the fluorescent receptor pairs whether
npg dous variation of the cytoplasmic sequences beyond the juxtamembrane region of IFN-γR1 relative to the extracellular domains among various tetrapod species. The most strongly conserved segments of the intracellular domains of IFN-γR1 are the areas required for function such as the Stat1 binding site and the Jak1 association sites (Figure 3 , left). The Jak2 association site is also strongly conserved among IFN-γR2 sequences from various tetrapod species (Figure 3, right) . Mutation of these segments eliminates the ability of Jak1, Jak2 or Stat1 to bind to the receptor and results in inactive receptor complexes [15, 19-21, 42, 45] . Mutation of Pro-284 in the Jak-kinase binding site of IFN-γR1 to an alanine residue virtually eliminated the Figure 2A, 2B) , we deduced that the decrease in FRET between IFN-γR1 and IFN-γR2 chains upon addition of IFN-γ ( Figure 1B, 1C) is due to the reorientation of the IFN-γR1 chain.
The presence of Jak1 in the receptor complex is required for preassembly IFN-γR1 and IFN-γR2 bind Jak kinases at their juxtamembrane segments [6, 7, 19, 20, 42, 44] . There is tremen- npg from human, pig, mouse, chicken, and frog were aligned and conserved regions are illustrated. Shading of conserved regions was done with the BOXSHADE algorithm with a stringency setting of 0.7. Black shading indicates identity with a consensus sequence, while grey shading indicates conservation with a consensus sequence. Putative secondary structure elements identified by sequence homology and based on the crystal structure of IFN-γR1 [55] are shown with a box.
IFN-γR2
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Kinases [1] . When IFN-γ was added to cells possessing FL-IFN-γR2/EBFP, FL-IFN-γR2/GFP and [P284L]IFN-γR1, there was a small decrease in FRET between the two IFN-γR2 chains (Figure 5B ). This decrease in FRET was less than that seen between two IFN-γR2 chains in the presence of intact IFN-γR1 (Figure 2A) . Thus, the absence of Jak1 binding to IFN-γR1 alters ligand-induced rearrangements between the IFN-γR2 chains.
The presence of Jak2 does not contribute to the preassembly of the receptor complex
Unlike IFN-γR1, a single amino acid mutation in the intracellular domain of IFN-γR2 did not eliminate the ability of IFN-γR2 to interact with Jak2, but mutation of one of two pentapeptide regions was necessary and sufficient to inhibit the coimmunoprecipitation (and presumably the binding) of Jak2 with IFN-γR2 [20] . To investigate the influence of the Jak2 association site in receptor complex preformation, we mutated the first pentapeptide region of FL-IFN-γR2/GFP from Pro 284 Pro 285 Ser 286 Ile 287 Pro 288 (numbering here includes the putative signal peptide but not the FLAG epitope) to alanines [20] ability of Jak1 to be immunoprecipitated with IFN-γR1 and resulted in a nonfunctional IFN-γ receptor complex when coexpressed with IFN-γR2 [19] . We mutated this proline to leucine in IFN-γR1/EGFP to create an AflII restriction site was generated so that mutated clones could be easily iden- The interactions between two IFN-γR2 chains in the presence or absence of Jak1 in the receptor complex were determined. We did not see a major difference in the FRET between the two IFN-γR2 chains whether or not the Jak1 recruitment site on IFN-γR1 was intact ( Figure 5A Cell Research | www.cell-research.com
Kinases, Stat1 and receptor chains in preassembly 64 npg IFN-γR1 or IFN-γR2 with their corresponding murine sequence does not alter biological activity of the human IFN-γ receptor complex [30] [31] [36] [37] . However, the extracellular domains of the human and murine IFN-γR1 and IFN-γR2 chains must originate from the same species for signal transduction to occur [4-5, 30-31, 33-37] . Thus we hypothesized that since the human and murine extracellular domains of each chain must match; murine-human chimeric receptor chains would interact more weakly with human receptor chains than human receptors react with each other. To test this hypothesis directly, the extracellular domain of FL-Hu-IFN-γR2/GFP was substituted with the murine homolog to create the chimeric murine:human fluorescent receptor MH-IFN-γR2/GFP. After the chimeric receptor chain was coexpressed with a human receptor chain, the FRET between the pair was compared to the FRET between the corresponding human receptor chains. Substitution of the IFN-γR2 extracellular domain with the mouse sequence affected its interaction with human receptor chains.
When MH-IFN-γR2/GFP was coexpressed with Hu-IFN-γR1/EBFP, FRET between these chains was reduced significantly ( Figure 7A The species-specificity barrier strongly affected interac- Figure  6D ) as observed with the native receptors. Though Jak2 is not required for receptor complex preassembly, it (like Jak1) is required for ligand-mediated restructuring that occurs in the intact fluorescent IFN-γ receptor complex in the presence of IFN-γ. The predominant role of Jak2 in activating the IFN-γ receptor complex is consistent with previous data showing the requirement for its kinase activity to observe phosphorylation of Tyr-457 of IFN-γR1 and Stat1 [22] .
Determinants in the extracellular domains differentially mediate receptor interactions
The site-directed mutagenesis of the intracellular domains described above did not disrupt the interaction seen between two IFN-γR2 chains in intact cells. Thus we suspected that mutation of the extracellular domain of IFN-γR2 may modify the interaction of IFN-γR2 with other receptor chains. To address this issue we used chimeric receptors. Substitution of the intracellular domains of either human Christopher D Krause et al. 65 npg in this report. This enabled us to discover that Stat1 must bind to IFN-γR1 to induce a significant change in liganddependant separation of the receptor chains; and that Jak1 but not Jak2 is required for preassembly of the IFN-γR1 and IFN-γR2 chains. Furthermore, interactions between IFN-γR2 chains required species-specific residues in their extracellular domains. Species-specific residues in the extracellular domain of IFN-γR2 also influence its interaction with IFN-γR1. We mutated IFN-γR1 at Tyr-457 to prevent Stat1 recruitment to the IFN-γR1 chain. This mutation did not inhibit FRET between [Y457F]IFN-γR1/EBFP and FL-IFN-γR2/ GFP in the absence of IFN-γ, but it eliminated the ligandmediated decrease in FRET efficiency ( Figure 1A, 1B) . To confirm this observation independantly, U3A cells lacking Stat1 were transfected with IFN-γR1/ECFP and FL-IFN-γR2/EYFP. These stable transformants demonstrated that the IFN-γR1 and IFN-γR2 chains are preassociated but the FRET could not be decreased in response to Hu-IFN-γ (Figure 1C, 1D) . Thus, Stat1 recruitment to IFN-γR1 produces the major IFN-γ-dependant change in separation between IFN-γR1 and IFN-γR2. Because this mutation on IFN-γR1 did not affect the interaction between two IFN-γR2 chains (Figure 2A, 2B) , we conclude that the interaction of Stat1 with the carboxyl terminus of IFN-γR1 primarily affects the structure of IFN-γR1, while the movement of the two IFN-γR2 chains requires the activation of the preassembled IFN-γ receptor complex by IFN-γ.
The absence of Stat1 (U3A cells; Figure 1 ) or the Y457F mutation on IFN-γR1 did not compromise any other aspect of the IFN-γ receptor complex as reported: IFN-γ is capable of inducing several hundred genes when Stat1 is deleted [46] [47] and the IFN-γ receptor is capable of inducing Stat1-independant genes in the presence of Stat1 when the IFN-γR1 chain contains the Y457F mutation [47] . Furthermore, when Tyr-457 is mutated, the resulting receptor is still capable of tyrosine phosphorylation of Jak1, Jak2, and Tyr-479 of IFN-γR1, which creates an evolutionarily conserved (Figure 3 ) recruitment site for SOCS-1 [48] . All except the last activity are known to require the presence and/or activity of Jak kinases [22, 46] . It can be inferred from these previous studies that the IFN-γ receptor complex was structurally and biologically intact. Here, we extend these studies to confirm directly that the IFN-γ receptor complex is intact structurally when Stat1 activation by IFN-γ is disrupted (Figures 1 and 2) .
Jak kinases bind to the intracellular domains of cytokine receptor chains, providing the IFN-γ receptor complex with tyrosine kinase activity necessary for the activation of Stat proteins. Cells lacking either Jak1 or Jak2 are unresponsive to IFN-γ [17, 18] . To determine the roles of these kinases in the preassembly of the IFN-γ receptor complex, we mutated tions between IFN-γR2 chains. FRET between MH-IFN-γR2/GFP and FL-IFN-γR2/EBFP almost disappeared ( Figure 7B , blue line), whereas coexpression of two human IFN-γR2 chains showed considerable FRET ( Figure 7B , green line). Therefore, elements in the extracellular domain controlling the interaction between IFN-γR2 chains are species-specific. Coexpression of Hu-IFN-γR1 with MH-IFN-γR2/GFP and FL-IFN-γR2/EBFP only slightly enhanced the FRET between this receptor pair (data not shown). It follows that elements in the extracellular domain of Hu-IFN-γR2 whose sequences diverge between human and murine receptors mediate the homotypic interactions.
Discussion
Previous concepts about the structure of the IFN-γ receptor complex were based on coprecipitation assays [9] [10] [11] [19] [20] . Jak1 and IFN-γR1 consistently coprecipitated with antibodies against the IFN-γR1 chain. Similarly, Jak2 and IFN-γR2 consistently coprecipitated with antibodies against IFN-γR2. However, coimmunoprecipitation of IFN-γR1 and IFN-γR2 was observed only in the presence of IFN-γ; similarly, coimmunoprecipitation of IFN-γR1 and Jak2 was observed only in the presence of IFN-γ. Thus the belief developed that IFN-γ assembled the signaling complex stepwise by first binding two IFN-γR1:Jak1 complexes and then two IFN-γR2:Jak2 complexes [6] [7] 44] . However, all these experiments were based on methodologies that disrupt the plasma membrane and microenvironment of the IFN-γ receptor. To determine the gross structure of the IFN-γ receptor complex in intact cells we used FRET and found that the receptor complex is preformed [1] , a result that indicated that the interaction between the IFN-γR1 and IFN-γR2 chains is too labile to survive immunoprecipitation. In this report we show that Jak1 binding to IFN-γR1 is required for the interaction between IFN-γR1 and IFN-γR2 ( Figure  4 ) that has never been observed in coimmunoprecipitations or other methods. These results underscore the importance of noninvasive technologies to better understand how the IFN-γ receptor complex and other receptor complex exist in their natural state.
In this report we investigated the domains of the IFN-γ receptor complex that mediate receptor complex formation as well as ligand-induced changes in FRET [1] by using a method that does not disturb the microenvironment of the IFN-γ receptor in intact cells. The use of FRET permits determination of the proximity of donor and acceptor chains because FRET is only observed when two proteins are very close together; this proximity usually infers a direct interaction between the proteins attached to the donor and acceptor chains. These direct interactions were disrupted by various alterations to the receptor complex described npg with both IFN-γR2 and IFN-γR1 chains. The interaction of IFN-γ with IFN-γR1 is species specific [30, 33, 34] . Thus, we believe that the overall species-specificity of murine and human IFN-γ for their receptors operates at two levels: binding of IFN-γ to IFN-γR1, and association of IFN-γR2 with IFN-γR1 and IFN-γR2 chains through their extracellular domains.
The results with the chimeric receptors suggested that interactions between two IFN-γR2 chains are mediated predominantly by their extracellular domains. It is reasonable to speculate that regions of the extracellular domain of IFN-γR2 whose primary sequences differ between human and murine IFN-γR2 chains participate in the interaction between IFN-γR2 and the IFN-γR1 and IFN-γR2 receptor chains. Comparisons of IFN-γR2 extracellular domains of humans, pigs, mice, chickens and frogs demonstrate that the residues predicted to be within β-pleated sheets are quite strongly conserved between the sequences, but greater variation occurs between the sequences in areas between the β-pleated sheets of the extracellular domain (Figure 3, right) .
Loops between β-pleated sheets in the extracellular domain mediate the receptor:receptor interaction in the erythropoietin receptor as predicted from its crystal structure. The same loops of the fibronectin III domains are used by the erythropoietin receptor to engage two different types of unrelated erythropoietin ligand agonists, an erythropoietin receptor antagonist, and the erythropoietin receptor chains [49] [50] [51] [52] . These binding loops (between sheets βC and βC' and sheets βE and βF of the NH 2 -terminal SD100 domain, and after sheet βG in the 3 10 helix between the two SD100 domains) of IFN-γR2 may in fact be responsible for the interactions of IFN-γR2 with IFN-γR1 and with IFN-γR2.
A model summarizing our data ( Figure 8 ) is expanded from our initial model [1] . The IFN-γ receptor complex is a preassembled entity ( Figure 8A , B, C), as constitutive interactions are seen between two IFN-γR2 chains ( Figure  6 , Figure 8B) , and between IFN-γR1 and IFN-γR2 ( Figures  1, 4, 6 , 7, 8A) in the absence of ligand. Within this receptor complex are interactions that are species specific and likely involving three loops of the extracellular domain of IFN-γR2) (Figure 8, purple shading) . Within the intracellular domain ( Figure 8D ), IFN-γR1 and IFN-γR2 are held together by an interaction involving Jak1 (Figure 4) , whereas Jak2 does not play an apparent role in receptor preassociation ( Figure 6 ). Because the interaction between IFN-γR2 and IFN-γR1 is very weak when Jak1 is not present, we believe that there is considerable dynamic dissociation and association between the extracellular domains of IFN-γR1 and IFN-γR2 ( Figure 8C) ; the IFN-γ receptor complex remains preassociated by the ability of Jak1 to tether IFN-γR2 to IFN-γR1 via their intracellular domains ( Figure 8D) . regions of the intracellular domain of IFN-γR1 or IFN-γR2 known to interact with Jak1 or Jak2, respectively, such that they could no longer interact with a Jak kinase. Mutation of the Jak2 binding site did not change the FRET significantly between FL-IFN-γR2/GFP and FL-IFN-γR2/EBFP ( Figure  6A ) or IFN-γR1/EBFP ( Figure 6B ). This suggests that mutagenesis of the Jak2 association site in the intracellular domain of IFN-γR2 does not grossly alter the structure of the intracellular domain of IFN-γR2 or the orientation of the EBFP and GFP moieties. Consequently, we conclude that Jak2 does not contribute to the preassembly of the chains of the IFN-γ receptor complex. In contrast, mutation of the Jak1 association site greatly diminished the FRET between the IFN-γR1 and IFN-γR2 chains ( Figure  4A ). Interestingly, ligand-dependant interactions were seen between two IFN-γR2 chains when the Jak1 site was mutated in IFN-γR1 ( Figure 5B ), though they were not as great as that seen in the presence of wild-type IFN-γR1 ( Figure 2B ). We hypothesize that Jak1 helps to facilitate the transient interaction between the extracellular domain of IFN-γR2 and the extracellular domain of either IFN-γR1 or the IFN-γ:IFN-γR1 complex by tethering IFN-γR2 to IFN-γR1 in their intracellular domains. Thus Jak1 but not Jak2 has a major role in the preassembly of the IFN-γ receptor complex by greatly enhancing the interaction between IFN-γR1 and IFN-γR2. A structural requirement for Jak1, particularly the kinase-like domain for a functional IFN-γ receptor complex was reported previously [22] but the nature of its structural role necessary for biological activity was not determined nor could a structural role for Jak2 be assessed. Our studies show that Jak2 plays no role in receptor complex preassembly but is required for ligand-mediated restructuring and is consistent with previous data showing the requirement for Jak2 kinase activity to observe any signaling by IFN-γ [22] . Because Jak2 did not influence receptor preassembly, the association of IFN-γR1 with IFN-γR2 by Jak1 does not occur through Jak2, but through IFN-γR2 directly or through another IFN-γR2-associated protein.
Because exchanging the extracellular domains of the IFN-γ receptor from human to mouse renders the IFN-γ receptor complex unable to bind or respond to Hu-IFN-γ, we examined if these domain changes could affect the interactions among the IFN-γ receptor chains. We found that replacing the extracellular domain of Hu-IFN-γR1 with its murine counterpart did not greatly change the FRET between it and either Hu-IFN-γR1 or Hu-IFN-γR2 (data not shown), but exchange of the extracellular domain of IFN-γR2 with the murine sequence decreased the extent of FRET significantly between both Hu-IFN-γR1 and Hu-IFN-γR2 (Figure 7) . Thus it appears that the speciesspecificity barrier due to IFN-γR2 affects its interaction
npg require that IFN-γR2, IFN-γR1 and IFN-γ be from closely related species. This requirement may arise because both receptor chains contact ligand directly. IFN-γR1 binds to IFN-γ directly [53] [54] [55] . No evidence of a direct interaction of IFN-γ to IFN-γR2 alone exists, however IFN-γ can be crosslinked to IFN-γR2 in cells expressing IFN-γR1 [11, 42, 56] . Additionally, the interaction of IL-19, IL-20, and IL-24 with IL-20R1 (the orthologous ligand-binding chain of these ligands) requires the formation of a binary complex of these ligands with IL-20R2 (the orthologous accessory chain of these ligands) [57] . The model proposes that first IFN-γ binds to the IFN-γR1 chains ( Figure 8E, 8F) , and then the IFN-γR2 chains interact with the IFN-γR1:IFN-γ: IFN-γR1 complex ( Figure 8G, 8H ). Jak1 keeps IFN-γR2 near IFN-γR1 so that a rapid association of IFN-γR2 to the IFN-γR1:IFN-γ:IFN-γR1 complex occurs. The Jak kinases then activate each other, and initiate the signaling cascade. Sometime after IFN-γR2 interacts with the IFN-γR1:IFN-γ: IFN-γR1 complex and probably after the Jak kinases are activated, the intracellular domains of the IFN-γR2 chains change their positions such that the FRET between them decreases ( Figure 8I ). The interaction of Stat1 with the IFN-γR1 chain results in a conformational change of the IFN-γR1 chain ( Figure 8J ) such that FRETS between IFN-γR1 and IFN-γR2 decreases.
To summarize, the IFN-γ-dependant movement between the IFN-γR1 and IFN-γR2 chains required that Stat1 bind IFN-γR1. Mutation of the Jak1 association site inhibited the interaction between IFN-γR1 and IFN-γR2, indicating that Jak1 is necessary for the interaction of these chains. Mutation of the Jak2 association site on IFN-γR2 has no effect on receptor preassociation, suggesting there is no obligatory role for Jak2 in preassembly of the receptor complex. Exchange of the extracellular domain of human IFN-γR2 from the human to the murine sequence disrupts its interactions with human IFN-γR2 and with human IFN-γR1 chains, implying that IFN-γR2 uses species-specific determinants in these interactions. Finally, interaction of the IFN-γ receptor complex with IFN-γ results in two conformational changes dependant on both Jak1 and Jak2. One involves a spreading of the two IFN-γR2 chains from each other. The second involves a Stat1-mediated movement of the IFN-γR1 chains from the IFN-γR2 chains. from the National Institute of Allergy and Infectious Diseases R01-AI043369, R01-AI36450 and R01-AI059465.
Changes in these interactions occur when IFN-γ binds to this preassembled IFN-γ receptor complex. These changes (J) Stat1, dimerized through the NH 2 -terminal domains prior to its tyrosine phosphorylation [59] [60] [61] , is recruited to the receptor when IFN-γR1 is phosphorylated; after its tyrosine phosphorylation and dissociation from the receptor complex, it forms SH2-mediated homodimers [62] . 
